TAPTIQOM 15mcg / 5mg / ml eye drops, solution in single-dose vial medication leaflet

S01ED51 tafluprost + timolol • Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents

This combination of tafluprost and timolol is used for the treatment of open-angle glaucoma and ocular hypertension. Tafluprost lowers intraocular pressure by increasing the outflow of aqueous humor, while timolol reduces the production of aqueous humor.

The medication is administered as eye drops, usually once daily, as directed by a doctor. It is important for patients to follow the usage instructions to achieve maximum efficacy.

Patients should be aware of potential side effects, such as eye irritation, redness, or a sensation of dryness in the eyes. It is important to inform the doctor of any unusual symptoms.

Common side effects include eye irritation, a burning or itching sensation, and gradual changes in iris color. In rare cases, allergic reactions, ocular inflammation, or a decrease in heart rate may occur. Patients should be informed of these risks before starting treatment.

General data about TAPTIQOM 15mcg / 5mg / ml

Substance: tafluprost + timolol

Date of last drug list: 01-07-2015

Commercial code: W61386001

Concentration: 15mcg / 5mg / ml

Pharmaceutical form: eye drops, solution in single-dose vial

Quantity: 30

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for tafluprost + timolol

Other substances similar to tafluprost + timolol